Navigation Links
PharmaNet Shares Expertise in Drug Development Outsourcing at the 2011 Partnerships in Clinical Trials Conference

PRINCETON, N.J., March 21, 2011 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of drug development services to the pharmaceutical, biotechnology, generic drug and medical device industries, announces its participation at the 19th Annual Partnerships in Clinical Trials Conference in Phoenix, Arizona from March 30 to April 1. PharmaNet and industry experts will discuss pertinent industry topics, including:

Thursday March 31

Impact of Reform on Biosimilar Drug Development

Dalvir Gill, Ph.D., President, Late Stage Development, PharmaNet and Greg Skalicky, Senior Vice President, Worldwide Business Development, PharmaNet

Proactive GCP Compliance and Quality Management Systems

Jeffrey P. McMullen, CEO, PharmaNet and John W. Hubbard, Ph.D., FCP, Senior Vice President Worldwide Head, Development Operations, Pfizer

Assess the Impact of Industry Consolidation on Change Management and Your Outsourcing Operational Model

Marisa Bower, Senior Director, Business Development, PharmaNet

Outsourcing Phase IV Observational Studies: A Different Animal?

Jeffrey Trotter, Executive Vice President, Phase IV Development, PharmaNet

Friday April 1

Challenges and Opportunities in the Global Arena in Pediatric Drug Development

Philippa Smit-Marshall, MBChB, FFPM, FICR, Vice President and General Manager of Pediatrics & Medical Sciences, PharmaNet; and Diane Hoffman, Associate Director, Clinical Research Pediatric Group, Johnson & Johnson

Conference attendees can learn more about PharmaNet's capabilities by visiting booth 901 in the exhibition hall where an international team of representatives will be available to discuss PharmaNet's expertise in helping clients reach their goal of delivering safe and effective therapeutics to patients.

About PharmaNet

PharmaNet, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit

Contact: Anne-Marie Hess
Phone:   (609) 951-6842

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Jeffrey Freitag Appointed Chief Medical Officer of PharmaNet
2. PharmaNet and Anapharm Europe Formally End Joint Venture
3. Catherine Derasp Joins PharmaNet as Vice President, Clinical Operations
4. PharmaNets Technology Investments Translate to Enhanced Client Service in Its Phase I Clinics
5. PharmaNet Launches New Brand Identity at Upcoming Industry Conferences
6. PharmaNet Development Group Announces Observational Research Survey
7. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
8. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
9. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
10. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
11. Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
Post Your Comments:
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... PawPaws brand pet supplements owned by Whole Health Supply ... health of felines. The formula is all-natural and is made from Chinese herbs that ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):